skip to main content

H.R. 1222: Congenital Heart Futures Reauthorization Act of 2017

This was a vote to pass H.R. 1222 in the House. The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law. This vote was taken under a House procedure called “suspension of the rules” which is typically used to pass non-controversial bills. Votes under suspension require a 2/3rds majority. A failed vote under suspension can be taken again.

H.R. 1222 would direct the Secretary of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), to enhance surveillance capabilities to track the epidemiology of congenital heart disease (CHD) and to provide grants to study the epidemiology of CHD across the lifespan. In addition, the legislation would require the Secretary report to Congress on CHD, including information on the demographics and health care utilization of individuals with the disease. Additionally, the bill would reauthorize research on CHD at the National Institutes of Health (NIH) and would require NIH to produce a report on its research efforts on CHD.

Congenital heart diseases (CHDs) are defects in the structure and function of the heart that disrupt the flow of blood through the heart. These defects range from simple to severe and life threatening. CHDs are the most common birth defect and the leading cause of infant mortality. Although the causes of CHDs among most infants are unknown, according to the CDC, at least 15 percent of all CHDs are associated with genetic conditions. Indeed, CHD is prevalent in individuals with Down syndrome; approximately half of all infants born with Down syndrome have cardiovascular defects.

Although advances in medical care permit adults and children with CHD to lead longer and healthier lives, disease management--especially in critical cases--still requires a lifetime of specialized cardiac care. Accurately tracking the prevalence, further understanding the causes, and identifying novel treatments will improve the lives of those living with CHD and decrease the risk of birth defects in the future.

Source: Republican Policy Committee

Totals

All Votes R D
Yea 92%
 
 
394
217
 
177
 
Nay 2%
 
 
7
7
 
0
 
Not Voting 7%
 
 
29
13
 
16
 

Date: Feb 26, 2018

Question: On Motion to Suspend the Rules and Pass, as Amended in the House

Required: 2/3

Result: Passed

Source: house.gov

Ideology Vote Chart

Key: R Yea D Yea R Nay
Seat position based on our ideology score.

Cartogram Map

Each hexagon represents one congressional district.

What you can do

Vote Details

Notes: The Speaker’s Vote? “Aye” or “Yea”?
Download as CSV

Statistically Notable Votes

Statistically notable votes are the votes that are most surprising, or least predictable, given how other members of each voter’s party voted and other factors.

All Votes